IRIS PubliCatt

Sora', Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.407
EU - Europa 3.147
AS - Asia 840
AF - Africa 39
SA - Sud America 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.380
DE - Germania 1.049
SE - Svezia 652
CN - Cina 486
IT - Italia 454
IE - Irlanda 237
UA - Ucraina 192
FR - Francia 161
SG - Singapore 151
GB - Regno Unito 149
FI - Finlandia 87
IN - India 77
RU - Federazione Russa 65
TR - Turchia 43
HK - Hong Kong 29
CI - Costa d'Avorio 27
BE - Belgio 18
CA - Canada 18
CZ - Repubblica Ceca 16
IR - Iran 16
ES - Italia 10
NL - Olanda 10
KR - Corea 9
HU - Ungheria 7
JP - Giappone 7
BR - Brasile 6
EG - Egitto 6
ID - Indonesia 6
PL - Polonia 6
AT - Austria 5
AU - Australia 5
CH - Svizzera 5
MX - Messico 5
VN - Vietnam 5
BZ - Belize 4
CL - Cile 4
RO - Romania 4
IL - Israele 3
LI - Liechtenstein 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
EE - Estonia 2
ET - Etiopia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
ZA - Sudafrica 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MN - Mongolia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 7.456
Salva come PNG Salva come JPEG
Città #
Chandler 632
Ashburn 379
Dublin 234
Woodbridge 178
Jacksonville 156
San Mateo 136
Dearborn 125
Nanjing 112
Wilmington 108
Fairfield 90
Houston 88
Ann Arbor 84
Beijing 84
Singapore 84
Cattolica 70
Milan 65
Seattle 63
Boston 62
Redmond 57
Rome 56
Princeton 55
Moscow 53
Nürnberg 53
Nanchang 51
Lancaster 49
Redwood City 49
Florence 48
Los Angeles 45
Marseille 45
New York 45
Lawrence 41
Bremen 38
Izmir 34
Chicago 32
Munich 31
Abidjan 27
Helsinki 25
Hong Kong 25
Kunming 25
Norwalk 24
Boardman 20
Brussels 18
Hefei 17
Leawood 17
Pune 17
Cambridge 16
Mountain View 16
Auburn Hills 15
Hangzhou 15
Lappeenranta 15
Shenyang 15
Brno 14
Fremont 13
Guangzhou 13
Hebei 13
Shanghai 13
Jiaxing 12
University Park 12
London 11
Tianjin 11
Changsha 10
Toronto 10
Frankfurt am Main 9
Zhengzhou 9
Mumbai 8
Philadelphia 8
Bologna 7
Budapest 7
Phoenixville 7
San Francisco 7
Seoul 7
Augusta 6
Washington 6
Changchun 5
Hanoi 5
Jinan 5
Lanzhou 5
North Hollywood 5
Wuhan 5
Albuquerque 4
Ardabil 4
Belize City 4
Buffalo 4
Chengdu 4
Edinburgh 4
Fuzhou 4
Kemerovo 4
Mexico City 4
Naples 4
Phoenix 4
San Diego 4
Aachen 3
Amsterdam 3
Andover 3
Arezzo 3
Bangalore 3
Busto Arsizio 3
Chatsworth 3
Cincinnati 3
Cleveland 3
Totale 4.157
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 348
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 300
Dasatinib first-line: Multicentric Italian experience outside clinical trials 261
Dasatinib first-line: Multicentric Italian experience outside clinical trials 261
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 223
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 141
Correlation between paraproteinaemia and viral reactivation after allo-SCT 134
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 132
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 129
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 123
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 122
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 112
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 109
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 102
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 101
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 100
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 100
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 99
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 99
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 95
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 94
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 89
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 89
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 88
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 86
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 84
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 77
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 76
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 76
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 68
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 67
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 65
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 65
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 63
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 63
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 62
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 62
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study 61
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 61
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 61
Unrelated cord blood transplantation and post-transplant cyclophosphamide 60
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 58
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 58
Unrelated cord blood transplantation and post-transplant cyclophosphamide 58
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 57
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 55
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 53
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 53
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 53
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 52
the concomitance of lymphoma and breast carcinoma in the bone 52
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 51
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 50
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 50
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 49
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry 48
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients 47
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 46
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 45
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 45
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 44
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 44
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice. 43
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 43
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 43
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 42
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. 42
The concomitance of lymphoma and breast carcinoma in the bone 41
Second haploidentical stem cell transplantation for primary graft failure 41
Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors 39
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: Incidence, clinical findings and outcome 39
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline 39
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study 39
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 39
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 39
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 39
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 39
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation 37
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 37
Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia 36
Residual peripheral Blood CD26+ leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and durin treatment- free Remission 35
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy 35
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 35
Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia. 34
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 34
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 34
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 33
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population 33
'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy 31
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. 29
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party 28
correction idelalisib exposure before allogenic stem cell transplantation in patients with follicular lymphoma an EBMT survey 27
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 26
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 26
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 25
Day 60 WT1 assessment on CD34 selected bome marrow better predicts relapse and mortality after allogenic stem cell transplantation in acute myeloid leukemia patients 23
Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: A salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma 23
treatment free remission in chronic myeloid leukemia fron-line with nilotinib 10 year followup of GIMEMA CML 0307 study 22
Totale 7.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.068 185 97 69 47 90 110 93 68 57 104 90 58
2020/2021950 362 128 38 44 55 47 45 13 71 17 112 18
2021/2022898 73 39 38 40 65 24 18 139 49 61 172 180
2022/20231.990 246 235 146 252 205 270 94 150 254 39 74 25
2023/20241.202 41 339 49 75 38 135 88 72 26 66 108 165
2024/202543 43 0 0 0 0 0 0 0 0 0 0 0
Totale 7.676